
Twitter, the microblogging platform, is the current rage in social media. According to @Shwen, who writes the Med 2.0 Blog, it grew by 752% in 2008.
(Feb 26, 2009)How many of you read the printed ingredients and nutrition fact boxes found on packaged foods to help you decide which of two similar products you ought to buy?
(Feb 27, 2009)For the past decade or so, I have worked as a career counselor at national scientific meetings where I present seminars about resume writing, interviewing techniques and other career related issues.
(Mar 4, 2009)Social media is the rage these days and, by all accounts, the things that are driving it popularity are making business connections, job hunting and the opportunity to meet/connect with others on a pe
(Mar 6, 2009)Merck announced today that it was buying Schering Plough, the Kenilworth-New Jersey based drug maker, for $41.1 billion.
(Mar 9, 2009)Some of you may have been wondering why the $41.1 billion Merck-Schering Plough merger announced yesterday was designed as a reverse merger.
(Mar 11, 2009)That methicillin resistant Staphylococcus aureus (MRSA) is in the news again is not surprising.
(Mar 12, 2009)As you all know by now, Merck announced on Monday that it will purchase Schering Plough for $41.1billion in a deal constructed as a reverse merger.
(Mar 14, 2009)As many of you know, the life sciences industry, one of the most highly regulated industries of the economy has been hesitant and reluctant to embrace social media to reach out to patients, physicians
(Mar 17, 2009)An audience of more than 150 senior industry professionals will be witness to this meeting of minds, marking the beginning of the two day event at the Regents Park Marriott Hotel in London.
Andrew Tolve investigates the value of the Internet as a pharma marketing research medium
Often criticised for not properly adopting new web technologies, pharma proves it knows a thing or two about the corporate website.
Alex Gochtovtt, principal with Cognizant’s enterprise analytics practice, discusses pharma’s social media opportunities and the importance of data analytics
An interview with Serkan Erkovan of Boehringer Ingelheim.
Ashok Bhaseen, Vice President of Sales & Marketing at Pediapharm reveals how his company establishes trust when engaging KOLs